{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:05:20Z","timestamp":1793833520745,"version":"4.6.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.seminoncol.2026.152483","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:06:51Z","timestamp":1773158811000},"page":"152483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer-associated fibroblasts in bladder cancer: Immunosuppressive mechanisms and therapeutic targeting"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8839-7767","authenticated-orcid":false,"given":"Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-5382","authenticated-orcid":false,"given":"Yongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seminoncol.2026.152483_bib0001","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J Glob Health"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152483_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0003","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152483_bib0004","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 Guidelines","volume":"87","author":"van der Heijden","year":"2025","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152483_bib0005","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA: Cancer J Clin"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152483_bib0006","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152483_bib0007","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152483_bib0008","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","article-title":"Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities","volume":"6","author":"Caramelo","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152483_bib0009","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1097\/JS9.0000000000001516","article-title":"Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T-cell-fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0011","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152483_bib0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41419-019-1581-6","article-title":"Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/er\u03b2\/Bcl-2 signaling","volume":"10","author":"Long","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","article-title":"Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects","volume":"32","author":"Cao","year":"2025","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1000888","article-title":"A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer","volume":"12","author":"Burley","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fcell.2020.00747","article-title":"Endothelial-to-mesenchymal transition in cancer","volume":"8","author":"Clere","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152483_bib0017","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"\u00d6hlund","year":"2014","journal-title":"J Exp Med"},{"issue":"32","key":"10.1016\/j.seminoncol.2026.152483_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202502774","article-title":"Single-cell RNA sequencing identifies MMP11+ cancer-associated fibroblasts as drivers of angiogenesis and bladder cancer progression","volume":"12","author":"Xu","year":"2025","journal-title":"Adv Sci"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152483_bib0019","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0020","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","article-title":"Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0021","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s42003-025-08094-9","article-title":"Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer","volume":"8","author":"Liu","year":"2025","journal-title":"Commun Biol"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152483_bib0022","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0023","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","article-title":"Cancer-associated fibroblast classification in single-cell and spatial proteomics data","volume":"14","author":"Cords","year":"2023","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.seminoncol.2026.152483_bib0024","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.3390\/cancers14133170","article-title":"Multiplex tissue imaging: spatial revelations in the tumor microenvironment","volume":"14","author":"Van Dam","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1522582","article-title":"Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis","volume":"15","author":"Feng","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12967-025-07534-8","article-title":"Single-cell and spatial atlas unveil tumor-specific microenvironment convergence and a prognosis-associated PLXDC1+ myofibroblast population in metastatic bladder cancer","volume":"24","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0027","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s42003-024-06426-9","article-title":"Digital spatial profiling of the microenvironment of muscle invasive bladder cancer","volume":"7","author":"Eyers","year":"2024","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0028","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ijo.2021.5239","article-title":"Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway","volume":"59","author":"Chen","year":"2021","journal-title":"Int J Oncol"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.668349","article-title":"CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion","volume":"11","author":"Gunaydin","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12935-024-03518-8","article-title":"The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152483_bib0031","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/2159-8290.CD-24-0131","article-title":"Cancer-associated fibroblasts serve as decoys to suppress NK cell anticancer cytotoxicity in breast Cancer","volume":"15","author":"Ben-Shmuel","year":"2025","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0032","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41467-025-56420-w","article-title":"Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer","volume":"16","author":"Lee","year":"2025","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006130","article-title":"Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6","volume":"11","author":"Lee","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"issue":"23","key":"10.1016\/j.seminoncol.2026.152483_bib0035","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1158\/1078-0432.CCR-24-1690","article-title":"At the interface of tumor-associated macrophages and fibroblasts: immune-suppressive networks and emerging exploitable targets","volume":"30","author":"Timperi","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1194642","article-title":"Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts","volume":"14","author":"Timperi","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152483_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19802","article-title":"The role of cancer-associated fibroblasts in bladder cancer progression","volume":"9","author":"Huang","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0038","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","article-title":"Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1","volume":"42","author":"Zhang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152483_bib0039","doi-asserted-by":"crossref","first-page":"810.e17","DOI":"10.1016\/j.urolonc.2019.05.005","article-title":"Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer","volume":"37","author":"Tsai","year":"2019","journal-title":"Urol Oncol: Seminars and Original Investigations"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","article-title":"Roles of cancer-associated fibroblasts (CAFs) in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Pei","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1340634","article-title":"Extracellular matrix remodeling in the tumor immunity","volume":"14","author":"Du","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0042","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nyas.14358","article-title":"Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection","volume":"1473","author":"Ghasemi","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1467602","article-title":"Targeting extracellular matrix stiffness for cancer therapy","volume":"15","author":"Feng","year":"2024","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152483_bib0044","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"issue":"6005","key":"10.1016\/j.seminoncol.2026.152483_bib0046","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-\u03b1","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0047","article-title":"Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0048","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.omtn.2020.11.003","article-title":"Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer","volume":"24","author":"Chen","year":"2021","journal-title":"Mol Ther-Nucleic Acids"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152483_bib0049","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s43587-024-00704-1","article-title":"Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion","volume":"4","author":"Meguro","year":"2024","journal-title":"Nat Aging"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0050","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/mmr.2015.3684","article-title":"VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin","volume":"12","author":"Zhu","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0051","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2020.00221","article-title":"Resistance mechanisms to anti-angiogenic therapies in cancer","volume":"10","author":"Haibe","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152483_bib0052","first-page":"3055","article-title":"Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer","volume":"17","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"issue":"7693","key":"10.1016\/j.seminoncol.2026.152483_bib0053","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumor response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"7693","key":"10.1016\/j.seminoncol.2026.152483_bib0054","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13046-022-02524-w","article-title":"The importance of being CAFs (in cancer resistance to targeted therapies)","volume":"41","author":"Rizzolio","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152483_bib0056","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1158\/0008-5472.CAN-23-1398","article-title":"Adipocyte precursor-derived NRG1 promotes resistance to FGFR inhibition in urothelial carcinoma","volume":"84","author":"Hosni","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0057","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13402-020-00500-0","article-title":"Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the wnt\/\u03b2-catenin pathway and upregulating PTEN","volume":"44","author":"Shan","year":"2021","journal-title":"Cell Oncol"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111956","article-title":"Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype","volume":"391","author":"Liu","year":"2020","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0059","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov"},{"issue":"23","key":"10.1016\/j.seminoncol.2026.152483_bib0060","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-05-2805","article-title":"Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts","volume":"65","author":"Lee","year":"2005","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152483_bib0061","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/j.1349-7006.2010.01695.x","article-title":"Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model","volume":"101","author":"Wen","year":"2010","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0062","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152483_bib0063","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0064","article-title":"Cancer-associated fibroblast heterogeneity: a factor that cannot be ignored in immune microenvironment remodeling","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152483_bib0065","article-title":"Epigenetic regulation of cancer-associated fibroblast heterogeneity","volume":"1878","author":"Kehrberg","year":"2023","journal-title":"Biochim Biophys Acta (BBA)-Rev Cancer"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152483_bib0066","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncb2756","article-title":"Mechanotransduction and YAP-dependent matrix remodeling is required for the generation and maintenance of cancer-associated fibroblasts","volume":"15","author":"Calvo","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152483_bib0067","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis","volume":"308","author":"Liu","year":"2015","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0068","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-022-01363-8","article-title":"Combination of oral STING agonist MSA-2 and anti-TGF-\u03b2\/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors","volume":"15","author":"Yi","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0069","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","article-title":"TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells","volume":"21","author":"Ping","year":"2023","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152483_bib0070","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0071","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12885-019-5353-6","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signaling","volume":"19","author":"Goulet","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0072","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2020.06.018","article-title":"Targeting Stat3 signaling impairs the progression of bladder cancer in a mouse model","volume":"490","author":"Korac-Prlic","year":"2020","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0073","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41467-024-45132-2","article-title":"The IL6\/JAK\/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer","volume":"15","author":"Amara","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152483_bib0074","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152483_bib0075","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI26532","article-title":"Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake","volume":"116","author":"Loeffler","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08859-5","article-title":"Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment","volume":"21","author":"Xue","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0077","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3389\/fimmu.2020.01956","article-title":"Anti-angiogenic agents in combination with immune checkpoint inhibitors: a promising strategy for cancer treatment","volume":"11","author":"Song","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152483_bib0079","doi-asserted-by":"crossref","first-page":"e1338","DOI":"10.1002\/ctm2.1338","article-title":"Integrated single-cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer","volume":"13","author":"Shi","year":"2023","journal-title":"Clin Transl Med"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0080","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0081","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","article-title":"Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response","volume":"14","author":"Arora","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152483_bib0082","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0083","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41391-024-00825-z","article-title":"Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer","volume":"28","author":"Fang","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0084","first-page":"2","article-title":"Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment","volume":"8","author":"Xie","year":"2025","journal-title":"Cancer Drug Resist"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152483_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107722","article-title":"A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer","volume":"26","author":"Qin","year":"2023","journal-title":"Iscience"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0086","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","article-title":"Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment","volume":"22","author":"Ma","year":"2023","journal-title":"Mol Cancer"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152483_bib0087","article-title":"Dampened regulatory circuitry of TEAD1\/ITGA1\/ITGA2 promotes TGF\u03b21 signaling to orchestrate prostate cancer progression","volume":"11","author":"Cruz","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0088","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1186\/s12885-024-12505-1","article-title":"Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumor aggressiveness in localized prostate cancer","volume":"24","author":"Ci","year":"2024","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152483_bib0089","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1158\/2159-8290.CD-24-0836","article-title":"Targeting noncoding cis-regulatory elements for cancer therapy in the context of the 3D genome","volume":"14","author":"Li","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.seminoncol.2026.152483_bib0090","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1002\/ctm2.1189","article-title":"Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: a tumor bulk and singlecell transcriptomic study","volume":"13","author":"Zheng","year":"2023","journal-title":"Clin Transl Med"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152483_bib0091","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00262-022-03255-9","article-title":"A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment","volume":"72","author":"Kuo","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152483_bib0092","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0093","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13007-023-01092-0","article-title":"NRTPredictor: identifying rice root cell state in single-cell RNA-seq via ensemble learning","volume":"19","author":"Wang","year":"2023","journal-title":"Plant Methods"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152483_bib0094","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1002\/imt2.156","article-title":"Gut microbiota reshapes cancer immunotherapy efficacy: mechanisms and therapeutic strategies","volume":"3","author":"Xie","year":"2024","journal-title":"Imeta"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:13:03Z","timestamp":1780319583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775426000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0093775426000308"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152483","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblasts in bladder cancer: Immunosuppressive mechanisms and therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152483"}}